Alligator Bioscience AB (publ)

Stockholm Stock Exchange:ATORX.ST

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

Location

Sweden

Market Cap

USD 24.35 M

Share Price

USD 0.62

Avg Daily Volume

377,133

Change (1 day)

10.33%

Change (1 year)

Change (YTD)

-20.43%

Alligator Bioscience AB (publ) EBIT for the year ending December 31, 2024: USD -19.28 M

Alligator Bioscience AB (publ) EBIT is USD -19.28 M for the year ending December 31, 2024, a -21.27% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Alligator Bioscience AB (publ) EBIT for the year ending December 31, 2023 was USD -24.49 M, a 33.03% change year over year.
Alligator Bioscience AB (publ) EBIT for the year ending December 31, 2022 was USD -18.41 M, a 18.13% change year over year.
Alligator Bioscience AB (publ) EBIT for the year ending December 31, 2021 was USD -15.58 M, a -10.08% change year over year.
Alligator Bioscience AB (publ) EBIT for the year ending December 31, 2020 was USD -17.33 M, a -22.18% change year over year.